Showing 1 - 10 of 30
Persistent link: https://www.econbiz.de/10010514735
Persistent link: https://www.econbiz.de/10010514724
Die Gesundheitssysteme stehen weltweit zur Diskussion. Kann internationales Benchmarking ganzer Gesundheitssysteme dazu beitragen, Lösungen für deren Probleme zu finden? Diese Arbeit stellt drei aktuelle Ansätze solcher Vergleiche vor. Hierbei werden die Erkenntnisse ebenso erläutert wie die...
Persistent link: https://www.econbiz.de/10010262913
Steigende Kosten in den meisten Gesundheitssystemen und die damit verbundenen Finanzierungsprobleme stehen im Focus von vielen empirischen Untersuchungen. Wissenschaftler sind der Meinung, dass falsch gesetzte Anreize einer der Hauptgründe hierfür darstellen. Die vorliegende Arbeit umreißt...
Persistent link: https://www.econbiz.de/10010262920
Persistent link: https://www.econbiz.de/10001808325
Persistent link: https://www.econbiz.de/10001896806
Increasing costs of most healthcare systems result in (major) financing problems and thus are the focus of many empirical inquiries. Researchers have found that mismanagement is often a consequence of misplaced incentives. This paper tries to outline some cases in which the demand side of...
Persistent link: https://www.econbiz.de/10005464729
The health systems are discussed worldwide. Is international benchmarking of whole health systems a potential tool to give answers to their problems? This paper introduces three current concepts of such comparisons. Their findings are explained as well as the problems, which are the background...
Persistent link: https://www.econbiz.de/10005606973
Introduction: Pulmonary rehabilitation (PR) aims to improve disease control in patients with chronic obstructive pulmonary disease (COPD) and asthma. However, the success of PR-programs depends on the patients' participation and willingness to cooperate. Taking the patients' preferences into...
Persistent link: https://www.econbiz.de/10014489899
Background: Since the implementation of the Regulation on Patient Integration (2003), the Act on the Reorganization of the Pharmaceutical Market (2011), and the Patient Rights Law (2013), the inclusion of patient perspectives has been further anchored in the German early benefit assessment...
Persistent link: https://www.econbiz.de/10014489931